You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Active rheumatoid arthritis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Carvedilol)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 25, 2023

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Rheumatoid Arthritis, Diet, Healthy, Inflammatory Response Trial in Mexico City (Plant-based diet for 14 days in patients with

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Plant-based diet for 14 days in patients with rheumatoid arthritis.
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Cardiología "Ignacio Chávez"
Jun 16, 2023

Rheumatoid Arthritis Trial (CT-P47 AI (tocilizumab), CT-P47 PFS (tocilizumab))

Not yet recruiting
  • Rheumatoid Arthritis
  • CT-P47 AI (tocilizumab)
  • CT-P47 PFS (tocilizumab)
  • (no location specified)
Feb 14, 2023

Rheumatoid Arthritis Trial in Saint Petersburg (Levilimab)

Active, not recruiting
  • Rheumatoid Arthritis
  • Saint Petersburg, Russian Federation
    X7 Clinical Research
Mar 23, 2023

Synovial and Adipose Tissue Composition in Overweight/Obese

Active, not recruiting
  • Rheumatoid Arthritis
  • Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
  • Rome, Italy
    Division of Rheumatology
Mar 2, 2023

Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

Recruiting
  • Arthritis, Rheumatoid
  • Placebo
  • +2 more
  • Upland, California
  • +2 more
Sep 1, 2023

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Not yet recruiting
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 25, 2023

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Rheumatoid Arthritis Trial in China (Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection)

Completed
  • Rheumatoid Arthritis
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
  • Beijing, Beijing, China
  • +14 more
Jul 21, 2023

Rheumatoid Arthritis Trial (Rebamipide, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Feb 21, 2022

Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs

Completed
  • Arthritis, Rheumatoid
    • Tokyo, Japan
      Pfizer
    Nov 28, 2022

    Rheumatoid Arthritis Trial (Fexofenadine, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • (no location specified)
    Feb 21, 2022

    Rheumatoid Arthritis Trial in United States (Certolizumab pegol)

    Completed
    • Rheumatoid Arthritis
    • Certolizumab pegol
    • Covina, California
    • +8 more
    Jul 26, 2022

    Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

    Recruiting
    • Rheumatoid Arthritis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 7, 2022

    Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

    Completed
    • Rheumatoid Arthritis
    • ISIS 104838
    • Birmingham, Alabama
    • +30 more
    Dec 1, 2022

    Rheumatoid Arthritis Trial (GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg)

    Withdrawn
    • Rheumatoid Arthritis
    • (no location specified)
    May 11, 2022

    Rheumatoid Arthritis Trial in Worldwide (JNJ-67484703, Placebo)

    Recruiting
    • Rheumatoid Arthritis
    • Anniston, Alabama
    • +13 more
    Aug 2, 2022

    Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))

    Completed
    • Moderately to Severely Active Rheumatoid Arthritis
    • Jiujiang, Jiangxi, China
      Jiujiang No.1 peoples's hospital
    May 4, 2022

    Oral Upadacitinib Tablets to Assess Adverse Events and Change in

    Recruiting
    • Rheumatoid Arthritis (RA)
    • +3 more
      • Bucheon, Gyeonggido, Korea, Republic of
      • +3 more
      Nov 8, 2022

      Rheumatoid Arthritis Trial in United States (Lovastatin, Placebo)

      Terminated
      Has Results
      • Rheumatoid Arthritis
      • Birmingham, Alabama
      • +14 more
      Aug 9, 2022

      Rheumatoid Arthritis Trial in Sofia (CT-P17 SC, Humira SC)

      Completed
      Has Results
      • Rheumatoid Arthritis
      • CT-P17 SC
      • Humira SC
      • Sofia, Bulgaria
        National Multiprofile Transport Hospital Tsar Boris III
      Oct 20, 2021

      Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)

      Not yet recruiting
      • Rheumatoid Arthritis
      • MBS2320 5 mg
      • +3 more
      • (no location specified)
      Jul 12, 2022

      Rheumatoid Arthritis Trial in Bydgoszcz (CT-P17 SC AI (adalimumab))

      Completed
      Has Results
      • Rheumatoid Arthritis
      • CT-P17 SC AI (adalimumab)
      • Bydgoszcz, Poland
        Nasz Lekarz Osrodek Badan Klinicznych
      Oct 19, 2021

      Rheumatoid Arthritis Trial (Iguratimod combined with Tofacitinib;)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Iguratimod combined with Tofacitinib;
      • (no location specified)
      Mar 26, 2023